LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?

Photo by lunarts from unsplash

Percutaneous coronary intervention (PCI) is the cornerstone of management for patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (1-6). Anticoagulation is routinely administered during PCI in order… Click to show full abstract

Percutaneous coronary intervention (PCI) is the cornerstone of management for patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (1-6). Anticoagulation is routinely administered during PCI in order to minimize the risk of thrombotic events. However, the choice of anticoagulation should be balanced with the risk of bleeding.

Keywords: heparin versus; versus bivalirudin; bivalirudin percutaneous; percutaneous coronary; coronary intervention

Journal Title: Journal of thoracic disease
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.